Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability

Vildagliptin is a selective and potent dipeptidyl peptidase-4 inhibitor that improves glycemic control by inhibiting the degradation of both endogenous glucagon-like peptide-1 and glucose-dependent insulinotropic peptide. This article is a comprehensive review of the safety and efficacy of vildaglip...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, CY, Wang, XL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694507/
https://www.ncbi.nlm.nih.gov/pubmed/23818788
http://dx.doi.org/10.2147/TCRM.S30071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694507/
https://www.ncbi.nlm.nih.gov/pubmed/23818788
http://dx.doi.org/10.2147/TCRM.S30071

Ejemplares similares